Drugmakers pledge to prioritize safety; WHO says ‘this will not be the last


Nine drugmakers working on coronavirus vaccines publicly pledged on Tuesday to prioritize safety and uphold rigorous scientific standards as concerns mount of political pressure to bring a vaccine to market before the Nov. 3 U.S. presidential election. The pledge sought to “ensure public confidence” by committing to only apply for regulatory authorization when enough data has been collected from a large phase three trial. Three vaccine manufacturers have now entered phase three trials. 

The following data was compiled by Johns Hopkins University:

  • Global cases: More than 27.3 million
  • Global deaths: At least 893,00
  • U.S. cases: More than 6.3 million
  • U.S. deaths: At least 189,200



Read More: Drugmakers pledge to prioritize safety; WHO says ‘this will not be the last

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.